Modelling the costs and effects of leflunomide in rheumatoid arthritis
β Scribed by G. Kobelt; P. Lindgren; A. Young
- Book ID
- 106294738
- Publisher
- Springer
- Year
- 2002
- Tongue
- French
- Weight
- 400 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1618-7598
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective Spontaneous reports of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) treated with leflunomide, a diseaseβmodifying antirheumatic drug (DMARD), have been appearing recently. To assess this risk, we conducted a populationβbased epidemiologic stud
## Objective: To report the safety and efficacy of leflunomide (lef) in combination with infliximab (inf) for the treatment of rheumatoid arthritis. ## Methods: In an open, multicenter, retrospective study, data were collected on the safety and efficacy of lef and inf. ## Results: Eighty-eight